Hoofdpijnonderzoek inclusief hoofdpijn behandelprotocol

Referenties
[32] Mitsikostas D., Thomas A. (1999) Comorbidity of headache and depressive disorders.
Cephalalgia; 19:211-17
[33] Oostendorp R. (1988) Functionele vertebrobasilaire insufficiëntie: onderzoek en
Behandeling. PhD Thesis, Nijmegen, Nederland: Katholieke Universiteit Nijmegen
[34] Mirzai R., Chang C., Greenspan A., Gerschwin ME. (1999) The pathogenesis of
osteonecrosis and the relationships to corticosteroids. Journal Asthma; 36:77-95
[35] Http://www.studiosus.nl/summary/files/pathofysiologie.doc
[36] Mueller L. (2007) Diagnosing and managing migraine headache. The Journal of the
American Osteopathic Association; 107(10 Suppl 6):ES10-6
[37] Granella F. et al. (1993) Migraine with and without aura and reproductive life events:
a clinical epidemiological study in 1300 women. Headache; 33:385-9
[38] Kuperfermann I. (1985) Hypothalamus en limbic system II. Motivation In: Kendal E.,
Schwartz J. et al. Principles of neural science. Amsterdam: Elsevier Sience
Publishers; 626–35
[39] Cutrer F., O'Donnell A., Sanchez del Rio M. (2000) Functional neuroimaging:
enhanced understanding of migraine pathophysiology. Neurology; 55(9 Suppl 2):S36-
45
[40] Bartolini M., Baruffaldi R., Paolino I., Silvestrini M. (2005) Cerebral blood flow
changes in the different phases of migraine. Functional neurology; 20(4):209-11
[41] Hadjikhani N., Sanchez del Rio M., Wu O. et al. (2003) Mechanisms of migraine aura
revealed by functional MRI in human visual cortex. Proceedings of the National
Academy of Science; 98:4687-92
[42] Http://www.encyclo.nl
[43] Olesen J., Diener H., Husstedt I. et al. (2004) Calcitonin Gene-Releated Peptide
Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine. The New
England journal of medicine; 350,1104-1110
[44] Brewerton T., Murphy D., Mueller E., Jimerson D. (1988) Induction of migraine like
headaches by the serotin agonist m-chlorophenylpiperazine. Clinical pharmacology
and therapeutics; 43:605-9
[45] Goldstein D., Roon K., Offen W. et al. (2001) Selective serotin IF (5-HT(IF)) receptor
agonist LY334370 for acute migraine, a randomized controlled trail. The Lancet; 358:
1230-4
[46] Goadsby P., Hoskin K., Storer R., Edvinsson L., Conner H. (2002) Adenosine (A1)
receptor agonist inhibit trigeminovascular nociceptive transmission. Brain; 1392-401
199